Calhoun Vision Finds $69M For Intraocular Lenses

Pasadena-based Calhoun Vision, a company which is developing implantable, light adjusting intraocular lenses used to treat cataract surgery, has raised $69.0M in a funding round, the company said today. The financing was led by Longitude Capital, and also included H.I.G. BioVentures, Balance Point Capital Partners, and RA Capital Management. The company, led by Rick Heinick, says it is developing a light adjustable lens which can be adjusted by physicians following cataract surgery, to adjust the power of those lenses to suit a patient in a post-operative procedure. The company says the funds will go towards supporting a current Phase III study of the product. The funding was split between $52M in equity and $17M in debt conversion. More information »